Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Mackall Website

Crystal L. Mackall, M.D.

Selected Publications

1)  Mackall CL.
Introduction to the series of reviews on "Antibody Derivatives as New Therapeutics for Hematologic Malignancies".
Blood. 123: 2283-4, 2014.
2)  Prieto DA, Johann DJ, Wei BR, Ye X, Chan KC, Nissley DV, Simpson RM, Citrin DE, Mackall CL, Linehan WM, Blonder J.
Mass spectrometry in cancer biomarker research: a case for immunodepletion of abundant blood-derived proteins from clinical tissue specimens.
Biomark Med. 8: 269-86, 2014.
3)  Duncan BB, Highfill SL, Qin H, Bouchkouj N, Larabee S, Zhao P, Woznica I, Liu Y, Li Y, Wu W, Lai JH, Jones B, Mackall CL, Bachovchin WW, Fry TJ.
A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapy.
J. Immunother. 36: 400-11, 2013.
4)  Haso W, Lee DW, Shah NN, Stetler-Stevenson M, Yuan CM, Pastan IH, Dimitrov DS, Morgan RA, FitzGerald DJ, Barrett DM, Wayne AS, Mackall CL, Orentas RJ.
Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia.
Blood. 121: 1165-74, 2013.
5)  van Den Brink M, Leen AM, Baird K, Merchant M, Mackall C, Bollard CM.
Enhancing immune reconstitution: from bench to bedside.
Biol. Blood Marrow Transplant. 19: S79-83, 2013.
6)  Zhang H, Maric I, Diprima MJ, Khan J, Orentas RJ, Kaplan RN, Mackall CL.
Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer.
Blood. 122: 1105-13, 2013.
7)  Brehm C, Huenecke S, Pfirrmann V, Rossig C, Mackall CL, Bollard CM, Gottschalk S, Schlegel PG, Klingebiel T, Bader P.
Highlights of the third international conference on immunotherapy in pediatric oncology.
Pediatr Hematol Oncol. 30: 349-66, 2013.
8)  Mackall C, Maris J.
Q&A: Crystal Mackall, John Maris on pediatrics.
Cancer Discov. 3: 961, 2013.
9)  Tumaini B, Lee DW, Lin T, Castiello L, Stroncek DF, Mackall C, Wayne A, Sabatino M.
Simplified process for the production of anti-CD19-CAR-engineered T cells.
Cytotherapy. 15: 1406-15, 2013.
10)  Lundström W, Highfill S, Walsh ST, Beq S, Morse E, Kockum I, Alfredsson L, Olsson T, Hillert J, Mackall CL.
Soluble IL7Ra potentiates IL-7 bioactivity and promotes autoimmunity.
Proc. Natl. Acad. Sci. U.S.A. 110: E1761-70, 2013.
Click Here to View Expanded Bibliography.

This page was last updated on 5/8/2014.